← Eichor
Condition: Chemotherapy Toxicity Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chemotherapy Toxicity

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients
NA · 1 location(s) · Dena h. Al-Tameemi · NCT07273812Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025
Phase N/A · 1 location(s) · Bernardino Clavo, MD, PhD · NCT05417737Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Horm
Phase N/A · 1 location(s) · University Hospital, Brest · NCT06621459Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therap
NA · 1 location(s) · The Cooper Health System · NCT06688422Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).
Phase 2/Phase 3 · 1 location(s) · Bernardino Clavo, MD, PhD · NCT06799351De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas
NA · 10 location(s) · Technische Universität Dresden · NCT03396718Aspects of Adjuvant CDK4/6 Inhibitors in Older Breast Cancer Patients - Focusing on Geriatric Screening
Phase N/A · 5 location(s) · Region Jönköping County · NCT07273357Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
EARLY_Phase 1 · 6 location(s) · New York Medical College · NCT03719105Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT06041477Investigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition.
Phase N/A · 2 location(s) · Universitair Ziekenhuis Brussel · NCT06387901Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Seconda
Phase N/A · 1 location(s) · Bernardino Clavo, MD, PhD · NCT06816095Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis
NA · 1 location(s) · University of Pavia · NCT07491536Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity
Phase 2 · 1 location(s) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador · NCT07018622Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China
Phase N/A · 2 location(s) · RenJi Hospital · NCT06717178Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients
NA · 1 location(s) · Mucosa Innovations, S.L. · NCT05635929Effect of an Amino Acids and Flavonoids Containing FSMP on Chemotherapy Toxicity, Nutritional Status and Quality of Life
NA · 1 location(s) · Flavolife Srl · NCT05968677Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients
Phase 2 · 1 location(s) · University Medical Centre Ljubljana · NCT07245069Impact of Gonadotoxic Therapies on Fertility
Phase N/A · 1 location(s) · Michael von Wolff · NCT05885048Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemother
NA · 1 location(s) · Dana-Farber Cancer Institute · NCT06923397Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in
NA · 1 location(s) · Azienda Sanitaria Locale di Asti · NCT07524829Investigating Cognitive Impairment in Young Patients With Cancer Prospectively
Phase N/A · 1 location(s) · Rigshospitalet, Denmark · NCT05840575Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications
Phase N/A · 1 location(s) · Sunnybrook Health Sciences Centre · NCT04053439Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers
NA · 1 location(s) · Wake Forest University Health Sciences · NCT06709404DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Phase 4 · 12 location(s) · Rutgers, The State University of New Jersey · NCT07158164Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
Phase 2 · 9 location(s) · Matrix Biomed, Inc. · NCT03480971The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity
Phase 3 · 1 location(s) · Zhejiang Cancer Hospital · NCT06214195Study to Evaluate the Use of Capecitabine in Monotherapy and in Combination With Oxaliplatin in Elderly Patients as Adju
Phase 2 · 1 location(s) · Nizhny Novgorod Regional Clinical Oncology Center · NCT06888843Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments
NA · 1 location(s) · Centre Hospitalier Metropole Savoie · NCT06274268Focal Radiotherapy Plus Low Dose Craniospinal Irradiation Followed by Adjuvant Chemotherapy in WNT Medulloblastoma.
NA · 1 location(s) · Tata Memorial Centre · NCT04474964Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer
NA · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT05984888
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.